2021 American Transplant Congress

TOPIC: Clinical Science

Transplant Center Provisional Yes Practices for Deceased Donor Kidneys
A. M. Placona¹, C. Martinez¹, H. McGehee¹, C. Van De Walker², J. Rosendale¹
Transplant Center Volume in High-risk Donors are Associated with Graft and Patient Survival
M. A. Merzkani, H. Murad, M. Mattu, M. Wang, V. Hu, S. Chang, T. Alhamad
Transplant Center Volume in High-risk Recipient Association with Graft and Patient Survival
M. A. Merzkani, H. Murad, M. Mattu, S. Husami, M. Wang, V. Hu, S. Chang, T. Alhamad
Transplant Data Platform – An Augmented Clinical Intelligence Framework
C. Focht, W. Tian, J. Zeng, N. Dzebisashvili, S. Ghosh
Transplant Decision Making Concerns for Asian Patients with End-Stage Kidney Disease
N. Singh¹, A. Wasim¹, G. Chawla¹, F. Jamil¹, M. Hamid¹, R. Siddiqui¹, E. Lui¹, N. El-Dassouki¹, M. Novak¹, A. D. Waterman², I. Mucsi¹
Transplant Glomerulopathy in the Absence of Donor-specific HLA Antibodies: Risk Factors, Histopathological Features and Graft Outcome
A. Senev, E. Van Loon, M. Emonds, M. Naesens
Transplant-free Survival in Alcohol-related Liver Disease (ALD) Patients Presenting with First Evidence of Ascites
K. Fahoum¹, N. T. Shen², E. Basu¹, J. Lee³, A. Kaplan², A. Salajegheh⁴, R. Rosenblatt², A. Jesudian², C. Lucero², B. Fortune², M. M. Safford⁵, R. S. Brown²
Transplantation of Hepatitis C Positive Kidney and Pancreas Allografts Into Hepatitis C Naïve Recipients – A Single Center Experience as a Standard of Care
K. Yadav¹, A. Padiyar², K. Zhao³, J. Rabets³, A. Jittirat², S. Sclair⁴
Transplanting Hepatitis C Infected Organs Into Uninfected Recipients: A Pharmacy Perspective
M. L. Holt, A. James, K. Gutierrez, T. Sparkman, J. Banbury, D. Jones
Treatment and Outcomes of Kidney Transplant Recipients with C4d Negative Antibody Mediated Rejection
M. Walsh, L. Lineberger, M. Brokhof, N. Kenyon, N. Alvey